Cost-effectiveness of a Tobacco Cessation Care Service in the Community Pharmacy (CESAR)

Sociedad Espanola de Farmacia Clinica, Familiar y Comunitaria

Status: Completed

Conditions: Pharmacist-Patient Relations; Smoking Cessation

Treatments: Behavioral: CESAR training

Study type: Interventional

Funder types: Other

Identifiers

NCT05461066

EPA-13-16

Details and patient eligibility

About

The study was a non-randomized controlled trial of 12-months' follow-up with 182 Spanish community pharmacists. Intervention community pharmacists received the CESAR training to improve their smoking cessation services, consisting of an initial interview and follow-up visits to identify obstacles and reinforce behaviours. The control group received the usual care. Data were self-reported and collected in a computerized health registration system. Outcomes were smoking cessation and quality of life (EuroQOL-5D) collected at baseline, 6 months', and 12 months' follow-up. Cost data were collected for the study period and included direct health costs, sick leave, and intervention costs. Smoking cessation was analysed through logistic regression models. Generalized linear models were carried out for quality-adjusted life year costs. Incremental cost-effectiveness ratios (ICERs) and cost-utility ratios (RCUI) were calculated. Sensitivity analyses were performed.

Enrollment: 800 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• smoker over 18 years old
• consent to participate
• presence at the community pharmacy for one of three reasons (a) a medical prescription for a treatment to stop smoking, (b) a consultation about how to stop smoking, (c) asking if he/she smokes when he/she consults for associated symptoms or harm.

Exclusion criteria

• cognitive impairment
• drug uses
• pregnancy or lactation.

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

800 participants in 2 patient groups

Intervention

Experimental group

Description:

Smoking cessation intervention in community pharmacies

Treatment:

Behavioral: CESAR training

Control

Active Comparator group

Description:

Usual care of smoking cessation in community pharmacies

Treatment:

Behavioral: CESAR training